Single cell‐derived clones from human adipose stem cells present different immunomodulatory properties
Author(s) -
Sempere J. M.,
MartinezPeinado P.,
Arribas M. I.,
Reig J. A.,
De La Sen M. L.,
Zubcoff J. J.,
Fraga M. F.,
Fernández A. F.,
Santana A.,
Roche E.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12270
Subject(s) - immunology , stem cell , adipose tissue , biology , microbiology and biotechnology , endocrinology
Summary Human adipose mesenchymal stem cells are a heterogeneous population, where cell cultures derived from single‐cell‐expanded clones present varying degrees of differential plasticity. This work focuses on the immunomodulatory/anti‐inflammatory properties of these cells. To this end, five single‐cell clones were isolated (generally called 1. X and 3. X ) from two volunteers. Regarding the expression level of the lineage‐characteristic surface antigens, clones 1·10 and 1·22 expressed the lowest amounts, while clones 3·10 and 3·5 expressed more CD 105 than the rest and clone 1·7 expressed higher amounts of CD 73 and CD 44. Regarding cytokine secretion, all clones were capable of spontaneously releasing high levels of interleukin ( IL) ‐6 and low to moderate levels of IL ‐8. These differences can be explained in part by the distinct methylation profile exhibited by the clones. Furthermore, and after lipopolysaccharide stimulation, clone 3. X produced the highest amounts of proinflammatory cytokines such as IL ‐1β, while clones 1·10 and 1·22 highly expressed IL ‐4 and IL ‐5. In co‐culture experiments, clones 1. X are, together, more potent inhibitors than clones 3. X for proliferation of total, CD 3 + T , CD 4 + T and CD 8 + T lymphocytes and natural killer ( NK) cells. The results of this work indicate that the adipose stem cell population is heterogeneous in cytokine production profile, and that isolation, characterization and selection of the appropriate cell clone is a more exact method for the possible treatment of different patients or pathologies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom